WiSys Technologies

26 WiSys Technologies in "Medical Imaging" or "Clean Technology" or "Micro & Nanotech" or "Pharmaceuticals & Vitamin D"

Benzodiazepine Derivatives with Reduced Side Effects

The WiSys Technology Foundation is seeking commercial partners interested in developing anxiolytic and anticonvulsant benzodiazepines that offer little or no side effects.

Warfarin Promoter for Enhanced Rodenticide Efficiency

WiSys is currently seeking a strategic partner to assist in such further development providing a route to market for the commercialization of lead analogues.